Navigation Links
Scientists map risk of premature menopause after cancer treatment
Date:8/22/2014

Women treated for the cancer Hodgkin lymphoma will be able to better understand their risks of future infertility after researchers estimated their risk of premature menopause with different treatments.

The findings, set out in the Journal of the National Cancer Institute, are based on the experience of more than 2,000 young women in England and Wales treated for the cancer over a period of more than 40 years.

Previous research has suggested that women with Hodgkin lymphoma who receive certain types of chemotherapy or radiotherapy are at increased risk of going through the menopause early but there was insufficient information to provide patients with detailed advice.

But the new study, led by scientists at The Institute of Cancer Research, London, provides precise estimates of risk for women depending on which treatment types and doses they received and at what age - allowing doctors to give them detailed advice about their risks of future infertility.

The research was largely funded by Breakthrough Breast Cancer and involved researchers from across the UK at more than 50 universities and hospitals.

The research team followed-up 2,127 women who had been treated for Hodgkin lymphoma in England and Wales between 1960 and 2004, and who had been aged under 36 at the time. All had received treatment with chest radiotherapy, sometimes alongside other treatments.

Some 605 of the women in the study underwent non-surgical menopause before the age of 40. This was a large enough number for the researchers to estimate accurate risks of menopause at different ages, depending on the mixture and doses of treatments they received and the age they received them.

The researchers produced a risk table which could help improve the advice that clinicians are able to give to women who have undergone treatment for the disease. Several of the treatments caused a sharp increase in premature menopause risk.

For example, a woman who had received six or more cycles of a standard chemotherapy regimen in her late 20s, but without receiving radiotherapy to the pelvic area, had a chance of around 18 per cent of undergoing menopause by the age of 30, or 58 per cent by age 40.

Overall, risk of premature menopause was more than 20-fold raised after ovarian radiotherapy, and also after some specific chemotherapy regimens. Risk of menopause by age 40 was 81 per cent after receiving ovarian radiotherapy at an overall dose of 5 or more Grays, and up to 75 per cent after chemotherapy, depending on the type, although only one per cent after receiving a chemotherapy regimen called ABVD.

Study leader Professor Anthony Swerdlow, Professor of Epidemiology at The Institute of Cancer Research, London, said:

"Hodgkin lymphoma often affects younger women, and although fortunately most survive the disease, treatments including certain types of chemotherapy and pelvic radiotherapy can lead to premature menopause.

"We hope our study will help women to understand better, in consultation with their doctors, their risks of future infertility following treatment for this malignancy. By looking in a much larger group of women than previous studies of this type, we were able to produce age and treatment specific risk estimates that we hope will be of practical use to individual women. I'm extremely grateful to the patients and doctors who made it possible for us to produce this information."


'/>"/>

Contact: Graham Shaw
henry.french@icr.ac.uk
020-715-35380
Institute of Cancer Research
Source:Eurekalert

Related medicine news :

1. Scientists show type-1 and type-2 diabetes are caused by same underlying mechanism
2. MIPT and RAS scientists made an important step towards creating medical nanorobots
3. Training the next generation of cancer nanomedicine scientists
4. Queens scientists in hospital superbugs breakthrough
5. USP Awards Early-Career Scientists with Fellowships Supporting Drug Quality Research
6. Scientists detail urgent research agenda to address chronic disease toll
7. Scientists make major breakthrough in understanding leukemia
8. Kessler Foundation scientists identify predictors of prospective memory deficit post TBI
9. Kessler Foundation scientists link environment & inclusion in adults with disabilities
10. CRI scientists pinpoint gene likely to promote childhood cancers
11. Scientists unlock key to blood vessel formation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2019)... (PRWEB) , ... May 14, 2019 , ... ... make it 27 of 32 professional football teams in the U.S. who rely ... “Our customers depend on our hydrotherapy solutions to accelerate healing,” said Timothy McCarthy, ...
(Date:5/14/2019)... ... May 14, 2019 , ... ... in the following majors: Health Science, Exercise Science, Psychology, and Business. These changes ... deans, and Provost, in order to ensure that each program best suits students’ ...
(Date:5/14/2019)... (PRWEB) , ... May 14, 2019 , ... ... hold the key to solving the world’s biggest health issues – ‘big data’. ... Digital Health CRC (Cooperative Research Centre), Stanford University and Southern Methodist University ...
(Date:5/14/2019)... ... May 14, 2019 , ... ChoiceSpine LLC, a privately-held spinal ... Food and Drug Administration (FDA) to market TIGER SHARK C interbody device with ... use together or separately in cervical spinal fusion procedures. , “BOOMERANG is ...
(Date:5/14/2019)... ... May 14, 2019 , ... Survival rates decline every year ... to a new study. , For each year diagnosis is delayed, the risk of ... issue of the Journal of Oral and Maxillofacial Surgery – the official journal of ...
Breaking Medicine News(10 mins):
(Date:5/16/2019)... ... 16, 2019 , ... Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today ... Series B is led by Kairos Ventures, with DEFTA Partners, Tech Coast Angels, and ... to expand the company’s ongoing Phase 1 / 2 clinical trial and fund development ...
(Date:5/16/2019)... , ... May 16, 2019 , ... ... and Dr. Peter D. Caie, Senior Research Fellow at St. Andrew University, UK ... EDT (2pm BST/UK) to learn about a deep learning based image analysis solution ...
(Date:5/15/2019)... ... May 15, 2019 , ... E.M.M.A. ... compliance services for the Medical Device industry, will be participating in a panel ... growing digital device field. Also, EMMA International will be delivering a course on ...
Breaking Medicine Technology: